Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
CA 2438174 A1 · Owner: Edwards, D. Scott · Inventors: Liu, Shuang; Edwards, D. Scott
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Detectably labeled macrophage scavenger receptor antagonists useful for the diagnosis and monitoring of various cardiovascular diseases including but not limited to atherosclerosis, vulnerable plaque coronary artery disease, renal , disease thrombosis, transient ischemia due to clotting stroke, myocardial , infarction, organ transplant organ failure and hypercholesterolemia.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 22, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 22, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 22, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.